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Markedly perturbed hematopoiesis in acid 
ceramidase deficient mice 
Acid ceramidase (ACDase) is ubiquitous and catalyzes the
degradation of ceramide. ACDase and ceramides have been
implicated in many disorders, including cancer, obesity, dia-
betes, inflammation, and neurodegenerative diseases.1-3
Deficiencies in ACDase activity lead to Farber disease, but
the specific role of this reaction in hematopoiesis has not
been clarified. We previously reported that Asah1P361R/P361R
mice have enlarged hematopoietic organs with leukocyto-
sis, specifically neutrophilia and monocytosis, along with an
excess of macrophages.4 Here we establish that the organ
enlargement is due to a gradual accumulation of foamy
macrophages, which destroys the tissue architecture.
Lymphoid progenitors in the bone marrow (BM) and thy-
mus of Asah1P361R/P361R mice were severely reduced over time
and myeloid progenitors were increased. Both progenitor
populations were not intrinsically altered by ceramide accu-
mulation and, importantly, were able to reconstitute a wild-
type (WT) mouse without inducing Farber disease.
Due to the rarity of patients diagnosed with Farber dis-
ease and their shortened lifespan, hematopoietic defects
have only been described superficially. Case reports have
mentioned some hematologic manifestations, but presenta-
tion has been inconsistent. These manifestations include
hepatosplenomegaly, enlargement and calcification of axil-
lary lymph nodes (LN), peripheral blood leukocytosis, ane-
mia, thrombocytopenia, and occasional nucleated RBCs.5-8
Most Farber patients present with subcutaneous nodules
that may contain foamy histiocytes.5-9 
Our first aim was to determine the cause of hematopoiet-
ic organ enlargement in our murine model of ACDase defi-
ciency. Surprisingly, the 3-12 fold enlargement of the
hematopoietic organs was not due to an increase in total
recoverable cells (Table 1). The cell number in the BM,
spleen, and thymus was actually reduced by 40%-85%, and
there was no significant difference in the cell number in the
LN. This decline in cell number occurs precipitously
between weeks 5 and 9, near the end of the lifespan of the
animal (data not shown). Instead, the hematopoietic organ
enlargement was due to foamy macrophages. An increase
of large, unstained (pale) areas could be detected in 9-week
old Asah1P361R/P361R animals in H&E stained sections (Figure
1A). These areas were B220– CD3– Mac-2+, suggesting cells
of the myeloid lineage. These Mac-2+ cells were much larger
in size than lymphocytes or Mac-2+ macrophages in WT BM
and were consistent with foamy macrophages described in
other LSDs.10,11 However, they were not “sea blue” after
May-Grunwald and Giemsa staining, as described in
Niemann-Pick disease.12 These macrophages were also F4-
80– CD23–, and could bind IgM (data not shown). From 5-9
weeks such foamy macrophages increased in size and num-
bers (data not shown). Histiocytic infiltrations have been
found in biopsies of the liver, spleen, BM, lungs, thymus,
LN, heart, spine, and peritoneal fluid of Farber patients.6,9,13,14
Furthermore, the age of onset of dermal nodules (filled with
histiocytes) has been suggested to correlate with life
expectancy.15 Antonarakis et al. describe a patient with nor-
mal peripheral blood (PB) counts initially that rapidly suc-
cumbed to the disorder as the PB counts increased; post-




Table 1. Weights and total cells isolated from WT, Het, and Hom Asah1P361R/P361R, and BMT mouse organs.
Measurement WT Het Hom BMT, Fold difference, Fold difference, Fold difference,
(unit ± SEM) (unit ± SEM) (unit ± SEM) (unit ± SEM) Hom/WT BMT/Hom BMT/WT
Body weight (g) 28.36±1.21 26.43±1.05 11.87±0.29 30.82±2.97 0.419x 2.60x 1.09x
*** *** N.S
Spleen % weight 0.29%±0.02% 0.29%±0.03% 1.2% ± 0.1% 0.92%±0.68% 4.10x 0.0621x 3.15x
*** N.S. N.S.
Thymus % weight 0.27%±0.02% 0.29%±0.02% 0.78% ± 0.12% 0.17% 3.00x 0.0101x 0.64x
*** N.D. N.D.
Lymph node 0.0089%±0.0020% 0.013%±0.001% 0.11%±0.01% 0.0049%±0.0008% 12.2x 0.0003x 0.56x
% weight *** *** N.S.
Liver % weight 5.4%±0.3% 5.3%±0.4% 7.4%±0.5% 4.9%±0.7% 1.37x 0.3774x 0.91x
** * N.S.
Kidney % weight 0.81%±0.08% 0.90%±0.11% 1.0%±0.1% 0.81%±0.08% 1.27x 0.0582x 0.99x
N.S. N.S. N.S
Total bone 4.17E7±0.55E7 N.D. 2.44E7±0.28E7 1.22E8±2.15E7 0.585x 5.0x 3x
marrow cells ** *** ***
per leg
Total spleen 1.17E8±0.26E8 N.D. 3.75E7±0.99E7 2.06E9±1.64E9 0.321x 55x 17x
cells ** * *
Total thymus 8.96E7±0.53E7 N.D. 1.42E7±0.63E7 4.2E8 0.158x 30x 5x
cells 0.63E7 *** N.D. N.D.
Total lymph 2.56E6±0.41E6 N.D. 4.01E6±1.93E6 N.D. 1.57x N.D. N.D.
node cells N.S.
WT, Het, and Hom Asah1P361R/P361R mice were weighed at age nine weeks. BMT mice were weighed at six months following control mice transplanted with age-matched
Asah1P361R/P361R donor cells. Body weight is expressed in grams (n=11-13 for WT, Het, Hom; n=4 for BMT). Organ values are expressed as percent of body weight (n=4-9 per group).
Lymph node weight was calculated by averaging 2-4 proper axillary and accessory axillary lymph nodes. Total cells were counted from bone marrow and spleen (n=15-16 for
WT, Het, Hom; n=4 for BMT) and from lymph nodes and thymus (n=4 per group, except for thymus BMT where n=1 (thymuses could not be seen in the other 3 mice)). Significance
for an unpaired, two-tailed t-test is listed under each fold difference. N.S.: nonsignificant; N.D.: not determined.
The macrophage infiltration into tissues was so severe in
our model that the architecture of the organs was altered.
While WT thymuses showed distinctive cortex and medul-
la, no such architecture could be detected in sections from
Asah1P361R/P361R mice after five weeks of age (Figure 1A). Flow
cytometry analyses revealed a time-dependent and precipi-
tous decline of the CD4+ CD8+ T cell populations in the thy-
muses of Asah1P361R/P361R mice from more than 77% in WT
mice to less than 9% in Asah1P361R/P361R mice by nine weeks,
with a similar decline in absolute cell numbers (Figure 1B
and C) that correlated with disease progression (Figure 1D).
A similar progenitor cell decline was seen in the BM where
flow cytometry analyses revealed a decline of B cell progen-
itor populations in Asah1P361R/P361R mice, both in population
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Figure 1. Asah1P361R/P361R mouse hematopoietic organs are filled with foamy macrophages, and have reduced but functional B and T cell pro-
genitors. (A) Staining of the thymuses of WT (top row) and Asah1P361R/P361R mice (middle row) at nine weeks with hematoxylin and eosin (H&E),
B220, CD3, and Mac-2 revealed fewer B220+ and CD3+ cells, and instead a massive increase of large, Mac-2+ cells reminiscent of foamy
macrophages. Destroyed cortex/medulla architecture of the thymus is seen. A similar accumulation of Mac-2+ cells and destruction of archi-
tecture were seen in the BM, spleen, and lymph nodes. Foamy macrophages are severely enlarged (bottom row; consecutive panels are a close
up of boxed area) Scale bar 50 µm. (B) Flow cytometry analysis was performed on thymuses from 9-week old WT and Asah1P361R/P361R thymuses
following staining for T cell markers. CD4+ CD8+ T cells comprise approximately 80% of the thymus in WT mice, yet are almost absent in
Asah1P361R/P361R mice. This population was present in BMT mice (control mice receiving Asah1P361R/P361R bone marrow). (C) The reduction in cell
population percentage is also seen when presented as absolute cell numbers. Significance was assessed using an unpaired, two-tailed t-test.
(D) CD4+ CD8+ cells are present in normal numbers in Asah1P361R/P361R mice at three and five weeks; a drastic decline is seen at seven and nine
weeks. Significance was assessed using a one-way ANOVA with Bonferroni post test. Data represent individual mice; line represents the mean.
(E) Flow cytometry analysis was performed on BM from 9-week old WT and Asah1P361R/P361R mice following staining for B-lineage markers. B cell
progenitors constituted a smaller percentage of total BM in Asah1P361R/P361R mice. This includes pro-B cell, pre-B cell, immature B cell, and tran-
sitional B cells. In contrast, mature B cells were present at a normal percentage in the BM. (F) The absolute number of B cell progenitors at
each progenitor stage were depleted, while mature B cells were maintained. Significance was assessed using an unpaired, two-tailed t-test for
each cell type. Data represent individual mice; line represents the mean. Pro: pro-B cell; Pre: pre-B cell; I: immature B cell; T: transitional B cell;
M: mature B cell. (G) To assess the functionality of mature lymphoid cells, spleen cells from 9-week old WT and Asah1P361R/P361R were stained
for CD19 to select for B cells. Their response to IL-7, LPS, and anti-mu in vitro was similar. Spleen cells selected for CD3 (T cells) were tested
for their response to conA and their response was also similar. n=4 per genotype for IL-7, LPS, and anti-mu. n=2 for conA. Experiment per-






percentages and absolute cell numbers at nine weeks (Figure
1E and F). As in the thymus, the decline began at 5-7 weeks
of age, but in contrast, the quantity of mature 
B cells was not affected. The missing T and B progenitors
were not found in the PB (data not shown). The coincidental
timing of the increase in macrophage infiltration into the
thymus and BM with the reduction in T- and B-progenitor
cells, respectively, suggests that destruction of the architec-
ture by macrophages may be disrupting the niche for devel-
oping cells.
Despite the absence of B and T cell progenitors in the BM
and thymus of Asah1P361R/P361R mice, respectively, mature B
and T cells were found in the circulation and organs. These
mature cells were able to respond to stimulation in vitro in
lymphocyte proliferation assays (Figure 1G). This demon-
strates that the mature B and T cells from this model main-
tain functionality. The presence of mature B and T cells at
an age where B and T progenitors are almost completely
depleted suggests that these cells were produced earlier in
the mouse’s life when B and T cell progenitors were present
and the environment was able to support differentiation.
Either the B and T progenitors lost their ability to differenti-
ate or the environment lost its ability to support them.
Arguing against the former explanation, the functionality of
the progenitor cells from Asah1P361R/P361R mice, as assessed in
vitro, appeared unaffected. B-cell progenitors from 9-week
old mice maintained the capacity to respond to IL-7 stimu-
lation in vitro (data not shown). Similarly, myeloid cells were
able to differentiate into all lineage types in in vitro colony-
forming cell (CFC) assays (Figure 2A).  The CFC results indi-
cate that the monocytosis reported in the PB of Asah1P361R/P361R
mice4 and the foamy macrophages found in their organs is
not due to a disproportionate increase of monocyte progen-
itor cells (CFU-M or CFU-GM) in the BM. Similarly, we pre-
viously reported that Asah1P361R/P361R mice have an excess of
RBCs,4 but it is not from a disproportionate increase of BFU-
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Figure 2. Myeloid progenitors are not intrinsically altered in Asah1P361R/P361R mice, and Asah1P361R/P361R BM is able to rescue lethally irradiated
control mice and is not sufficient to induce Farber disease. (A) Myeloid cells were assessed by CFC assay. Colony types were scored by
visual examination. The differentiation ability of the progenitors in the BM, spleen, and liver of Asah1P361R/P361R mice were not significantly
different from WT and Het mice. Significance was assessed by a two-way ANOVA with Bonferroni post test. (B) More myeloid progenitors
are present in the BM of Asah1P361R/P361R mice compared to WT and Het mice at all ages. In the spleen, fewer colonies were in the spleen
of Asah1P361R/P361R mice at seven weeks compared to WT mice. In the liver, an increase in myeloid progenitors was seen at five weeks, which
declined over time. CFU-Meg were rare in the CFC of both WT and Asah1P361R/P361R assays and were not included in the counts. Significance
was assessed by a two-way ANOVA with Bonferroni post test. n=6-7 per genotype per week for CFC assays. CFU: colony forming unit; G:
granulocyte; M: monocyte; GM: granulocyte/monocyte; GEMM: granulocyte/monocyte/megakaryocyte/erythrocyte; BFU-E: burst forming
unit erythrocyte. (C) BM from 9-week old mice was stained for lineage markers, Sca1 and cKit (LSK) to identify HSPC. An increase in the
percentage of LSK cells was seen in BM from Asah1P361R/P361R mice. A similar increase was seen in the absolute number of LSK cells (data
not shown). Significance was assessed by a one-way ANOVA with Bonferroni post test. n=8 for WT and Asah1P361R/P361R; n=3 for Het. (D) BM
enriched for HSPC by 5-fluorouracil pre-treatment of donors was transplanted from Asah1P361R/P361R mice into lethally irradiated WT mice
(BMT). Asah1P361R/P361R cells were able to reconstitute the hematopoietic system of the recipients. BMT mice had a lifespan longer than
untreated Hom mice (range indicated by arrows). Control mice not receiving a BMT after radiation had a lethality rate of 85%. Significance
was assessed by a log rank Mantel-Cox test.
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E (Figure 2A). Instead these cells may be from the liver:
Asah1P361R/P361R livers contained many more myeloid CFCs
than control livers at five weeks, with the difference gradu-
ally decreasing at seven and nine weeks (Figure 2B).
Extramedullary hematopoiesis has been noted in one very
severe Farber disease patient that died three days after
birth,9 and would be consistent with emergent granu-
lopoiesis observed during inflammation. Indeed, an accu-
mulation of granulocytes was seen in the thymuses, LNs,
and spleens of our Asah1P361R/P361R mice, as determined by
Mac-1 and Gr-1 staining (data not shown).
Interestingly, there was an increase in total myeloid pro-
genitor cell colonies seen in BM from Asah1P361R/P361R mice at
five, seven, and nine weeks (Figure 2B). The results of the
CFC assay were recapitulated by flow analyses of lineage–
Sca1+ cKit+(LSK) cells; Homozygous BM at nine weeks had
an increase in LSK cells (Figure 2C). The difference in colony
numbers in the CFC assays in samples originating from
Asah1P361R/P361R mice was smaller at nine weeks compared to
five and seven weeks. Spleen myeloid progenitors were
decreased in Asah1P361R/P361R mice only at seven weeks but, like
the BM, the differentiation potential was similar to cells
from WT controls (Figure 2A and B). 
Together, the presence of mature B and T cells that appear
functional, and the assessment of myeloid progenitors by
the CFC assay data, suggest that lymphoid and myeloid pro-
genitor cells themselves are not negatively affected by
ACDase deficiency. Instead, we hypothesize that there is a
degeneration of the niche that can no longer support these
lineages. To support this hypothesis, we tested the ability of
the myeloid and lymphoid cells to differentiate in a normal
environment in vivo by transplanting Asah1P361R/P361R donor
cells into WT and Het mice. The Asah1P361R/P361R donor cells
(BMT) were able to reconstitute hematopoiesis in this nor-
mal environment at 60%-100% donor chimerism at eight
months post transplant, as measured by CFC assay with
and without G418, and PCR of these colonies. Infusion of
the Asah1P361R/P361R donor cells did not result in the WT recip-
ient mice developing signs of Farber disease. The mice sur-
vived past the lifespan of Farber mice (Figure 2D), main-
tained a normal body weight (Table 1), and did not develop
leukocytosis (data not shown). The spleen, LN, liver, and thy-
mus sizes were reduced to normal WT sizes (Table 1). The
total amount of cells recovered from the BM, spleen, and
thymus of BMT mice was greater than in control WT or
Asah1P361R/P361R animals. In addition, these organs were not
filled with foamy Mac-2+ macrophages (data not shown). The
single thymus that was found had a normal proportion of
CD4+ CD8+ T cells (Figure 1B). Similarly, B-cell progenitors
were present at normal levels (Figure 1E). Together, these
data suggest that Asah1P361R/P361R hematopoietic cells alone are
not sufficient to induce Farber disease in a WT environment.
Alternatively, WT tissues transferred low levels of function-
al ACDase to the donor Asah1P361R/P361R cells through man-
nose-6-phosphate receptor-mediated uptake. 
These data show for the first time that systemic ACDase
deficiency leads to the generation of an abnormal
hematopoietic environment that initiates histiocytosis,
which in return leads to the complete destruction of organ
architecture. ACDase deficiency does not appear to intrinsi-
cally affect the differentiation of hematopoietic progenitor
cells, but our data suggest it has a detrimental effect on the
developmental niche for hematopoietic cells. Identifying the
roles of ACDase and ceramide at important junctures in
hematopoiesis is critical for understanding and developing
therapies for Farber disease and other disorders in which
ceramide accumulates, including inflammation, cancer, obe-
sity, and diabetes. 
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